FTC to Go After PBMs

PBMs are in the crosshairs of Washington, as their role in driving up drug costs for ordinary consumers becomes clearer to legislators and their…

Read More

PBM Consolidation Could Worsen ‘Spread Pricing’ in 2022

In a recent survey conducted by the National Community Pharmacy Association (NCPA), 95% of pharmacy owners said they're ‘significantly concerned’ about…

Read More